Influenza A NP(366-374) Strain A/PR/8/35 – 1 mg

Overview

Expand your research capabilities with our Influenza A NP(366-374) Strain A/PR/8/35 peptide, specifically designed for immunological studies. This peptide is an H2-Db-restricted epitope derived from the nucleoprotein of Influenza A/PR/8/34. It plays a crucial role in antigen presentation, making it a valuable tool for vaccine development, diagnostics, and understanding immune responses to Influenza A viruses.

Key Features

• High purity for reliable results
• Specifically synthesized for H2-Db binding
• Supports research in immunology and virology
• Ideal for use in assays and vaccine studies
• Available for immediate purchase

Specifications

FAQ

What is the primary use of this peptide?

This peptide is primarily used in research related to immune responses, specifically to study the H2-Db presentation of Influenza A antigens.

How pure is the Influenza A NP(366-374) peptide?

Our peptide is synthesized to high purity levels, ensuring that your experiments yield consistent and accurate results.

Can this peptide be used in vaccine research?

Yes, the Influenza A NP peptide is an excellent candidate for use in vaccine development studies, helping to evaluate immune responses.

Whether you’re examining immune mechanisms or developing diagnostic tools, the Influenza A NP(366-374) peptide is a must-have addition to your research toolkit. Order yours today to enhance your studies and gain insights into Influenza A infections.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.